Metastatic Colorectal Cancer (CRC) research hub

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

This study is testing a new drug called ivonescimab for bowel cancer that has spread. It compares ivonescimab with a standard treatment, bevacizumab, both given alongside regular chemotherapy. The aim is to see if ivonescimab works better as a first treatment.

A two-part, open-label, clinical study to assess the safety, tolerability and activity of intravenous doses of ICT01 in combination with low-dose subcutaneous interleukin-2 in patients with advanced solid tumors (EVICTION-2)